Raam S, Teixeira T
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1219-23. doi: 10.1016/0277-5379(85)90019-7.
The quantity of steroid hormone receptors in human mammary carcinomas is of importance for predicting clinical response to hormone modes of therapy. There have been several reports describing an increase in the yield of cytosolic receptors when sodium molybdate is included in the tumor cytosol. Since the quantitative units for receptors are fmol hormone bound per mg cytosolic protein, we examined whether this oxyanion had an interfering or enhancing effect on two methods of protein measurements: those of Bio-Rad and of Lowry. Our results showed that sodium molybdate, even when present in a 5 mM concentration in the protein solution, interferes with the color development by both reagents. This effect of molybdate is consistent, reproducible and statistically significant. We present the data to caution the investigators to be aware of this phenomenon while interpreting their own data on the molybdate effect on steroid receptors.
人类乳腺癌中类固醇激素受体的数量对于预测激素治疗方式的临床反应具有重要意义。已有多篇报道称,当在肿瘤细胞溶质中加入钼酸钠时,胞质受体的产量会增加。由于受体的定量单位是每毫克胞质蛋白结合的飞摩尔激素,我们研究了这种含氧阴离子对两种蛋白质测量方法(即Bio-Rad法和Lowry法)是否有干扰或增强作用。我们的结果表明,即使钼酸钠在蛋白质溶液中的浓度为5 mM,它也会干扰两种试剂的显色反应。钼酸盐的这种作用是一致的、可重复的且具有统计学意义。我们展示这些数据是为了提醒研究人员在解释他们自己关于钼酸盐对类固醇受体影响的数据时要注意这一现象。